bio2018-mybio-sessionicon-companypres

Actinogen Medical Ltd

4:00 PM–4:15 PM Jun 4, 2018 (US - Eastern)

Theater 1, Level 0

Description

To update the biotech, pharmaceutical and investment markets on the ongoing development of Xanamem

Session ID: 22075

Tags